$Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products$

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products

Acute graft-versus-host disease (GVHD) is a life-threatening complication that can develop after allogeneic hematopoietic stem cell transplantation. In particular, the prognosis of patients with steroid-refractory acute GVHD is extremely poor. Ryoncil™ (remestemcel-L), a human bone marrow-derived me...

Full description

Bibliographic Details
Main Authors:	Makoto Murata, Takanori Teshima
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Immunology
Subjects:	graft-versus-host disease (GVHD) mesenchymal stem cell (MSC) steroid ruxolitinib thymoglobulin
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.724380/full

Similar Items

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
by: Abedin S, et al.
Published: (2020-11-01)

Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
by: Dong Wang, et al.
Published: (2021-06-01)

Investigating host versus donor T cell chimerism in cutaneous graft versus host disease
by: Khatib, Laila
Published: (2020)

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
by: Mauricio Sarmiento Maldonado, et al.
Published: (2017-12-01)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
by: Enrico Maffini, et al.
Published: (2016-08-01)

The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease
by: Robert Ali, et al.
Published: (2017-11-01)

A real life use of ruxolitinib in patients with acute and chronic graft versus host disease refractory to corticosteroid treatment in Latin American patients
by: Mauricio Sarmiento, et al.
Published: (2021-07-01)

Mesenchymal Stem Cell Therapy in the Treatment of Acute and Chronic Graft versus Host Disease
by: Partow eKebriaei, et al.
Published: (2011-07-01)

Clinical efficacy and safety of ruxolitinib in treatment of chronic graft versus host disease
by: HUANG Xiaoli, et al.
Published: (2019-12-01)

Local immune cell infiltration in cutaneous acute graft versus host disease
by: Rachel Sennett, MD, PhD, et al.
Published: (2020-09-01)

Graft versus host disease occurring in living donor liver transplant
by: Nalini Bansal, et al.
Published: (2018-01-01)

ORAL GRAFT VERSUS HOST DISEASE: A REVIEW
by: Reddy Lavanya, et al.
Published: (2016-03-01)

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
by: Nikolas von Bubnoff, et al.
Published: (2018-11-01)

Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness
by: Lambros Kordelas, et al.
Published: (2019-04-01)

HPV32‐related Heck’s disease in a chronic graft‐versus‐host disease patient with long‐term successful KTP laser treatment: A rare case report
by: Joe Truong Nguyen, et al.
Published: (2021-05-01)

Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease
by: Xinyi Zhou, et al.
Published: (2020-04-01)

Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
by: Olle Ringdén, et al.
Published: (2020-10-01)

Etanercept on steroid-refractary acute graft-versus-host disease
by: Silvia González Munguía, et al.
Published: (2015-02-01)

The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease
by: Bo Tang, et al.
Published: (2018-05-01)

PHARMACOECONOMIC ANALYSIS OF DIFFERENT METHODS FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT-VERUS-HOST DISEASE: SINGLE-CENTER STUDY
by: I. S. Moiseev, et al.
Published: (2018-03-01)

An update on the clinical utility of extracorporeal photopheresis in the treatment of graft-versus-host disease
by: Salem B, et al.
Published: (2017-03-01)

Molecular Analysis of Oligoclonal T cells Associated with Graft-Versus-Host Disease Following Allogeneic Stem-cell Transplantation
by: Avent, Kassi
Published: (2012)

ST2/MYD88 signaling is a therapeutic target alleviating murine acute graft-versus-host disease sparing T regulatory cell function
by: Griesenauer, Brad
Published: (2018)

Immunosuppressive properties of Wharton's jelly derived mesenchymal stromal cells in the treatment of graft versus host disease in rat model
by: Lopez Rodriguez, Yelica Virginia
Published: (2013)

Extracorporeal Photopheresis for Steroid-refractory Chronic Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
by: Runzhe Chen, et al.
Published: (2015-01-01)

Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
by: Cynthia Morata-Tarifa, et al.
Published: (2020-02-01)

MSCs Become Collagen-Type I Producing Cells with Different Phenotype in Allogeneic and Syngeneic Bone Marrow Transplantation
by: Robert Maximilian Rusch, et al.
Published: (2021-05-01)

Exploiting Cell Death Pathways for Inducible Cell Elimination to Modulate Graft-versus-Host-Disease
by: Corey Falcon, et al.
Published: (2017-06-01)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
by: Mehrdad Hefazi, et al.
Published: (2021-09-01)

Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease
by: Meng-Zhu Shen, et al.
Published: (2021-09-01)

Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease
by: M.C. Nogueira, et al.
Published: (2007-12-01)

The Effect of Different Titers of Blood-Grouping Reagents on Proliferation and Apoptosis of Bone Marrow Derived Mesenchymal Stem Cells
by: Habibe Meltem Özgüner, et al.
Published: (2018-12-01)

Biomarkers in graft versus host disease after allogeneic hematopoietic stem cell transplant
by: Geary, Joshua J.
Published: (2016)

Clinical and morphological diagnostics of skin manifestations in case of graft-versus-host disease
by: A. YU. Krivolapova, et al.
Published: (2017-08-01)

Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis
by: Uta Gehlsen, et al.
Published: (2021-06-01)

Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial
by: Liren Qian, et al.
Published: (2020-11-01)

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
by: Peilong Lai, et al.
Published: (2018-12-01)

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
by: Tik Shing Cheung, et al.
Published: (2020-06-01)

Eculizumab treatment in a patient with hematopoietic stem cell transplantation-associated thrombotic microangiopathy and steroid-refractory acute graft versus host disease
by: Cristina Fernández, et al.
Published: (2015-12-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)